Boehringer Ingelheim Corporation and Eli Lilly and Company (LLY) Release: Phase III Safety and Efficacy Data of Trajenta® (linagliptin) in Elderly People With Type 2 Diabetes Published in The Lancet
8/15/2013 10:47:52 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
comments powered by